Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) Gross Profit (2020 - 2025)

Historic Gross Profit for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $84.5 million.

  • GeneDx Holdings' Gross Profit rose 7672.75% to $84.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $280.1 million, marking a year-over-year increase of 7622.97%. This contributed to the annual value of $194.4 million for FY2024, which is 11598.23% up from last year.
  • GeneDx Holdings' Gross Profit amounted to $84.5 million in Q3 2025, which was up 7672.75% from $70.9 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Gross Profit ranged from a high of $84.5 million in Q3 2025 and a low of -$29.6 million during Q2 2022
  • Over the past 5 years, GeneDx Holdings' median Gross Profit value was $18.8 million (recorded in 2023), while the average stood at $23.9 million.
  • Per our database at Business Quant, GeneDx Holdings' Gross Profit crashed by 244278.35% in 2022 and then surged by 28837.44% in 2023.
  • GeneDx Holdings' Gross Profit (Quarter) stood at -$2.8 million in 2021, then plummeted by 481.82% to -$16.3 million in 2022, then surged by 288.37% to $30.8 million in 2023, then surged by 115.27% to $66.2 million in 2024, then rose by 27.67% to $84.5 million in 2025.
  • Its last three reported values are $84.5 million in Q3 2025, $70.9 million for Q2 2025, and $58.5 million during Q1 2025.